BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11473078)

  • 1. Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
    Boccuzzi SJ; Wogen J; Fox J; Sung JC; Shah AB; Kim J
    Diabetes Care; 2001 Aug; 24(8):1411-5. PubMed ID: 11473078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of insulin secretagogues in the treatment of type 2 diabetes.
    Luna B; Hughes AT; Feinglos MN
    Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
    Inzucchi SE
    JAMA; 2002 Jan; 287(3):360-72. PubMed ID: 11790216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes management: a comprehensive clinical review of oral medications.
    Quillen DM; Kuritzky L
    Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes.
    Caro JJ; Klittich WS; Raggio G; Kavanagh PL; O'Brien JA; Shomphe LA; Flegel KM; Copley-Merriman C; Sigler C
    Clin Ther; 2000 Jan; 22(1):116-27. PubMed ID: 10688395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of type 2 diabetes mellitus.
    Feinglos MN; Bethel MA
    Med Clin North Am; 1998 Jul; 82(4):757-90. PubMed ID: 9706120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic therapy for type 2 diabetes mellitus.
    DeFronzo RA
    Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing type 2 diabetes. A look at the newer agents.
    Larmore SS
    JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral pharmacologic management of type 2 diabetes.
    Riddle MC
    Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.
    Brown DL; Brillon D
    J Natl Med Assoc; 1999 Jul; 91(7):389-95. PubMed ID: 10643211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
    Ramsdell JW; Braunstein SN; Stephens JM; Bell CF; Botteman MF; Devine ST
    Pharmacoeconomics; 2003; 21(11):819-37. PubMed ID: 12859222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted glycemic control in type 2 diabetes.
    Skyler JS
    J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
    [No Abstract]   [Full Text] [Related]  

  • 20. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.